PFE
34
-7
LEG
58
-4
COF
67
2
AME
66
-3
CA
27
9
BAX
50
-3
EQT
47
-4
ZTS
19
2
ALLE
41
-9
ADP
62
-3
TRV
48
-10
RSG
50
-4
EOG
32
-14
DVA
49
-3
MET
64
-2
AIG
74
-4
ITW
37
-6
MU
56
-6
DGX
36
-4
ED
42
-3
PFE
34
-7
LEG
58
-4
COF
67
2
AME
66
-3
CA
27
9
BAX
50
-3
EQT
47
-4
ZTS
19
2
ALLE
41
-9
ADP
62
-3
TRV
48
-10
RSG
50
-4
EOG
32
-14
DVA
49
-3
MET
64
-2
AIG
74
-4
ITW
37
-6
MU
56
-6
DGX
36
-4
ED
42
-3
Financhill
Back

Allied Properties Real Estate Investment Trust Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
25

APYRF
Allied Properties Real Estate Investment Trust

Last Price:
$9.56
Seasonality Move:
1.27%
Sell
36

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.60
Seasonality Move:
36.18%
Sell
25
Allied Properties Real Estate Investment Trust (APYRF) is a Sell

Is Allied Properties Real Estate Investment Trust a Buy, Sell or Hold?

  • The current Allied Properties Real Estate Investment Trust [APYRF] share price is $9.56. The Score for APYRF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • APYRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APYRF Stock Price Chart

What is Allied Properties Real Estate Investment Trust's stock price today?

  • The Allied Properties Real Estate Investment Trust share price today is $9.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APYRF is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $71.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

APYRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 41.05 Sell
Chaikin Money Flow: -19615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.23 - 9.69) Buy
Bollinger Bands (100): (10.31 - 14.51) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.27 Sell
Relative Strength Index (14 RSI): 37.77 Sell
Chaikin Money Flow: -61015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.54 - 86.44) Sell
Bollinger Bands (100): (44.45 - 88.87) Buy

APYRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.44 Buy
20-day SMA: 9.38 Buy
50-day SMA: 10.96 Sell
200-day SMA: 12.07 Sell
8-day EMA: 9.49 Buy
20-day EMA: 9.64 Sell
50-day EMA: 10.69 Sell
200-day EMA: 12.06 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.09 Sell
20-day SMA: 80.86 Sell
50-day SMA: 83.38 Sell
200-day SMA: 51.78 Buy
8-day EMA: 75.84 Sell
20-day EMA: 78.85 Sell
50-day EMA: 77.98 Sell
200-day EMA: 56.35 Buy

Allied Properties Real Estate Investment Trust Earnings Growth & APYRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Allied Properties Real Estate Investment Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):